NEVANAC (NEVAC NEPAFENAC) SUSP OFT 5ML

NEVANAC (NEVAC NEPAFENAC) SUSP OFT 5ML

Oftalmi Código del producto: 7591196007254-7

Medicamentos | Medicamentos | Antiinflamatorio

Precio:

Ref. 20.52

Bs.1,999.06

Volver

Compartir en:

Relacionados

Relacionados

Ver Todos

Diclofenac Sod 50 Mg X 10 Tab Caplin Poi

Precio a consultar

Nimesulide+paracetamol X 10 Tab Arte Med

Ref. 1.13

Bs.110.08

Diclofenac Sod (diclofevin) 50 Mg X 10 C

Ref. 1.04

Bs.101.32

Eusilen 4 Mg X 15 Comp

Ref. 4.36

Bs.424.75

Tantum 50 Mg X 20 Grageas

Ref. 3.12

Bs.303.95

Metilprednisolon Depo-medrol 40mg/ml Amp

Ref. 7.93

Bs.772.54

Valtrum Rollon X 50 Gr

Ref. 3.98

Bs.387.73

Duotrav Sol Oft X 2.5 Ml Alcon

Ref. 19.50

Bs.1,899.69

Betametasona Crema 0.1% X 15gr Inmenol

Ref. 4.42

Bs.430.60

Metilprednisolona (curesole) 125mg X 1 A

Ref. 2.45

Bs.238.68

Metilprednisolona 500 Mg X 1 Amp Cr Medi

Ref. 5.76

Bs.561.14

Arnica Rhelen Spray X 120ml

Ref. 2.93

Bs.285.44

Diclofenac Pot 50 Mg X 20 Tab Aless

Ref. 1.25

Bs.121.78

Dermosupril C 0.1% Crema X 15g Medihealt

Ref. 10.74

Bs.1,046.29

Inmunoglobuln (v-immune) 5 G Amp 100ml

Ref. 364.00

Bs.35,460.88

Misma Marca

Misma Marca

Ver Todos

Meloxicam (movimex) Tab 15 Mg X 10 Tab

Ref. 4.80

Bs.467.62

Levocetirizina Jbe 5mg/ml 60 Ml Levorat

Ref. 3.13

Bs.304.92

Quinotic Sol Otica X 4 Ml Oftalmi

Ref. 11.75

Bs.1,144.69

Bimatoprost+timolol (gampress) Sol Oft

Ref. 16.30

Bs.1,587.95

Aflamax 50 Mg X 20 Tab Oftalmi

Ref. 2.12

Bs.206.53

Budenas Susp At/nasal 50mcg X 200 Dosis

Ref. 9.11

Bs.887.50

Clarasol Sol Oft X 15 Ml Oftalmi

Ref. 1.98

Bs.192.89

Fisiolin Sol Nasal Ped X 15 Ml Oftalmi

Ref. 5.70

Bs.555.29

Solumar Sol. Hipertonica X 60ml

Ref. 8.93

Bs.869.96

Acetaminofen 500mg (apiret) X 10 Tab Oft

Ref. 1.17

Bs.113.98

Quinotic Sol Otica X 5 Ml

Ref. 3.80

Bs.370.20

Soltin Sol Oft X 15 Ml

Ref. 5.60

Bs.545.55

Airon 4 Mg Ped X 30 Tab Oftalmi

Ref. 4.76

Bs.463.72

Moxidex Sol Oft X 5 Ml Oftalmi

Ref. 15.71

Bs.1,530.47

Quinomax 0.50% Sol Oft X 5 Ml

Ref. 16.23

Bs.1,581.13